1.SCI's major business is including below three (3) items:
（1）APIs, API intermediates, special and Custom Synthesis (Development , manufacturing)（2）Supporting for bidding and distribution of products from domestic and overseas manufacturers as a local partner.
（3）Represent for Development of products in item 2.
2. Sales
Unit：NTD in thousand| Product | Y2024 | Ratio |
| API | 1,087,553 | 71.37% |
| Intermediate | 416,085 | 27.31% |
| Others | 20,100 | 1.32% |
| Total | 1,204,159 | 100.00% |
3.Product list and Services：
| Category | Product list |
|
API
| VA Probucol Divalproate Sodium Propafenone Hydrochloride Duloxetine Hydrochloride Allopurinol Clindamycin palmitate HCl Articaine Hydrochloride HOCLQ-Sulfate Brinzolamide Sodium Valproate Pentobarbital Sodium Methylphenidate HCl Biso-FA必 Thiopental acid Loxoprofen Sodium Hydrate Atomoxetine HCl Cannabidiol Adenine Buprenorphine UDP-Glu-Naz |
|
Intermediates | DEDPM |
| Specialty Chemical | DEK... etc. total in 7 items |
4. Sales areas of major products
